MiniMed Group, Inc. Common Stock (MMED) - Total Liabilities
Based on the latest financial reports, MiniMed Group, Inc. Common Stock (MMED) has total liabilities worth $1.02 Billion USD as of April 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
MiniMed Group, Inc. Common Stock - Total Liabilities Trend (2024–2026)
This chart illustrates how MiniMed Group, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. See MiniMed Group, Inc. Common Stock defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
MiniMed Group, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of MiniMed Group, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
PT Alamtri Resources Indonesia Tbk
JK:ADRO
|
Indonesia | Rp1.42 Billion |
|
Nanjing Iron & Steel Co Ltd
SHG:600282
|
China | CN¥40.33 Billion |
|
FLSmidth & Co.
CO:FLS
|
Denmark | Dkr12.59 Billion |
|
MDU Resources Group Inc
NYSE:MDU
|
USA | $4.78 Billion |
|
Klabin S.A.
SA:KLBN11
|
Brazil | R$46.51 Billion |
|
Mattel Inc
NASDAQ:MAT
|
USA | $4.22 Billion |
|
Hanwha Solutions
KO:009830
|
Korea | ₩22.93 Trillion |
|
Zhejiang Dingli Mach Co Ltd
SHG:603338
|
China | CN¥5.93 Billion |
Liability Composition Analysis (2024–2026)
This chart breaks down MiniMed Group, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see MiniMed Group, Inc. Common Stock balance sheet assets.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.92 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MiniMed Group, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MiniMed Group, Inc. Common Stock (2024–2026)
The table below shows the annual total liabilities of MiniMed Group, Inc. Common Stock from 2024 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-04-30 | $1.02 Billion | +17.13% |
| 2025-04-30 | $870.00 Million | +34.67% |
| 2024-04-30 | $646.00 Million | -- |
About MiniMed Group, Inc. Common Stock
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin t… Read more